LENZ Therapeutics, Inc.

21.66 USD
-0.15 (-0.69%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

LENZ Therapeutics, Inc. stock is up 18.23% since 30 days ago. The next earnings date is Nov 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 July’s closed higher than June.

About LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.